药学研究2025，Vol.44Issue(2)：145-149,5.DOI:10.13506/j.cnki.jpr.2025.02.008
新质生产力助力药品监管高质量发展的路径研究
Study on the path of new quality productivity to promote high quality development of drug regulation
摘要
Abstract
General Secretary Xi Jinping's series of important expositions and major deployments on new quality productivity have provided a basic guideline for the high-quality development of drug regulation.This paper focused on the development path of new quality productivity in China's drug regulation.At present,China's drug innovation in some tracks has realized the change from running behind to running in parallel,and the renewal of the structure of the pharmaceutical industry has accelerated,hence the characteristics of the new quality productivity of the drug regulatory object are gradually unfolding.The main factors driving the new quality productivity of drug regulation are laborers and labor tools,and that means the regulatory personnel and regulatory tools.Existing problems include a large shortage of high-quality regulatory personnel;Traditional regulatory tools are difficult to meet the demand;And a smart regulatory model has not yet been fully established.Accordingly,specific measures are proposed to cultivate innovative talents in regulatory science in the new era,accelerate the innovation of drug regulatory tools and promote the innovation of drug regulatory models,with a view to accelerating the development of new quality productivity in drug regulation and contributing to the high-quality development of drug regulation.关键词
新质生产力/药品监管/创新Key words
New quality productivity/Drug regulation/Innovation分类
药学引用本文复制引用
元延芳..新质生产力助力药品监管高质量发展的路径研究[J].药学研究,2025,44(2):145-149,5.基金项目
国家药品监督管理局药品监管科学体系建设重点项目(No.RS2024G002) （No.RS2024G002）
